Saturday, October 04, 2014 10:21:10 AM
The stock market is based on predictions. I own one bio-tech stock that is currently trading at $1.50. Roth Capital has an $8.00 price target on the stock. The company has a market cap of about $51M with $36M in cash and a number of drugs in its pipeline. Is Roth lying if it doesn't go to $8.00? I don't think so.
When I posted that I wouldn't be surprised if the number of shares would be increased by 500M or more I was was told by a number of posters how stupid I was for suggesting such a thing and that I was just being negative and that there was no need for the additional shares and Gerald would never do such a thing. How did that work out?
If you really believe in the company then you should welcome a lower share price with the opportunity to buy cheaper shares.
When the LymPro data was delayed at the C4CT conference and I stated that the share price was going significantly lower anyone who was thinking about buying AMBS shares would have profited more from my advice than from listening to those that were saying to buy it when it was at .15 or higher.
As to what any of the "whales" are posting I assume that you believe they don't have an agenda. LOL!!!
As I said before anyone can be ignored including you.
p.s. I don't attribute "greatness" to anyone posting on any of these boards.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM